Gafisa SA Is Wasting Away In Alphaville

The entire world may drool over the BRICs, but in terms of spinoffs only the ‘B’ (as in Brazil) seems to matter. Homebuilder Gafisa SA (GFA) is the country’s latest potential spin opportunity as the company announced that it is considering its strategic options – a phrase that often includes a sale, IPO or spinoff – for its Alphaville Urbanismo SA project.… Read More »

Sears Rights Offering Distribution Is Set For Today

The next round of corporate action at Sears Holding (SHLD) is about to begin as the board of directors set today as the distribution date of the rights offerings to purchase shares of its Hometown & Outlet store spinoff. The new company is expected to trade under the ticker ‘SHOS’ and each SHLD shareholder will receive one rights offering, good for… Read More »

New Research Confirms Spinoff Outperformance

Do spinoffs actually outperform the market? We often receive this question and point to Joel Greenblatt’s work and some other older studies. Luckily there are other people still examining the data for us and new research by Credit Suisse’s quantitative team (highlighted in this Barron’s ‘Focus on Funds’ blog) suggests the answer is still yes. According to CS’s findings, when… Read More »

Weak Earnings For Dell Means Time To Spinoff PCs?

Anyone have any new ideas? I know we have mentioned this numerous times – sorry – but the business and investing world is chock full of followers. We recently wrote about one example in the defense industry, but alas, it is not an isolated case. Take the PC business. IBM (IBM) successfully converted itself into a very profitable software business by dumping… Read More »

SAIC Follows Spinoff Trend – Will Split Government Services Business

If a certain investing strategy delivers returns then you can count on followers and imitators joining the party. Just google ‘how to invest like buffett’. Even this site is an offshoot of Joel Greenblatt’s successful investment strategy. Corporate strategy is the same, especially in the minds of analysts in the investing world – if an idea worked for one company then every company in the… Read More »

Update Time – A Few Spins Which Got Sold Instead

Time for a little housecleaning as we catch up on some old news regarding a few potential spins which ended up as sales instead. Can’t win them all. Loral Space & Communications (LORL) had long talked about spinning off its Space Systems/Loral (SSL) unit to shareholders, but instead sold the division to MacDonald, Dettwiler & Associates (TSX:MDA) for $875m. The… Read More »

Life’s A Party At Fiesta Restaurant Group($FRGI)

It’s been a scant three months since Fiesta Restaurant Group(FRGI) was spun out of Carroll’s(TAST) but the new company has already produced impressive results in its first reported quarter.  The stock, which began trading in May below $13, closed at $16.16 yesterday. Last week, Fiesta reported its results for the second quarter. The company showed strong comparable store… Read More »

Liberty Interactive – Not a Spinoff (Well, Sort Of)

For followers of John Malone and his family of companies, frequent restructurings are nothing new.  And he continues to provide special situation investors plenty to do.  On the heels of the announced Starz spin, Liberty Interactive executed a previously announced splitoff of the company into new tracking stocks Liberty Interactive (LINTA) and Liberty Ventures (LVNTA).  Since the company is remaining one… Read More »

Verint To Swallow Majority Owner Comverse After It Spins Off Comverse

Back in January, we reported that Comverse Technology(CMVT) would be spinning off subsidiary Comverse, Inc., leaving the parent with majority ownership of Verint(VRNT), as well as Starhome, a private company. We speculated at the time that the company would then follow up by distributing its Verint shares and winding down the holding company. Today, it was announced that… Read More »

Elan To Spin Off Drug Discovery Business, Neotope Biosciences, By Yearend

What do you do when your drug discovery costs swamp your profits from a successful marketed drug.  If you’re Elan Corporation(ELN), you spin off your drug discovery business with a bundle of cash, keeping your marketed drugs and late stage pipeline. Elan, an Irish biotech firm, is driven largely by Tysabri,a multiple sclerosis drug marketed with Biogen Idec(BIIB).… Read More »